Lonza

Lonza, established in 1897, stands as a premier global supplier serving the pharmaceutical, biotechnology, and specialty ingredients markets. The company provides an extensive, high-tech portfolio of services and products, including active pharmaceutical ingredients, nutritional ingredients, and advanced microbial control technologies designed to address harmful pathogens. By prioritizing innovation and global health advancement, Lonza supports complex drug development, manufacturing, and supply chain processes for a diverse range of clients worldwide.

Operating with over 10,000 employees across 33 global locations, the firm maintains a robust international operational footprint. Learn about Lonza's global headquarters for detailed geographic and operational insights regarding their Swiss-based infrastructure. The company leverages advanced manufacturing capabilities, including automated and robotic systems, to deliver high-quality biopharmaceutical solutions, gene therapies, and essential chemical components for diverse industrial and consumer applications.

Lonza competes with major industry players such as Pfizer, Catalent, and Albemarle, maintaining a strong market position through its specialized Pharma & Biotech and Specialty Ingredients segments, which generated $8.9B in annual revenue. Meet Lonza's team to understand the leadership driving these strategic initiatives and organizational growth. With a commitment to paperless operations and cutting-edge bioscience, the company continues to address critical challenges in healthcare, water treatment, and consumer health, ensuring the consistent delivery of high-value, science-based products to its extensive global client base.